我國藥師專業執業繼續教育現況之探討

A Study on Active Status about Continuing Pharmacy Education Standard in Taiwan

陳佩玉(Pei-Yu Chen)

指導教授 ： 溫燕霞

高雄醫學大學/藥學院/藥學研究所碩士在職專班/碩士(2005年)

摘要

藥師在提供藥事照顧及參與決策性政策的規劃與實施時，均應以改善病患醫療照護及降低醫療成本為最終目標。由於經濟環境成長快速，大眾對醫療品質要求增加，再因醫療體制的變動、全民健康保險的實施與醫藥分業的推行，更凸顯藥事服務不能再單以執行調配業務為主，故專業技能與知識之實踐為藥師專業發展之必須，而繼續教育亦為藥師專業發展的重要工具之一。本研究針對各專業執業藥師對「全民健康保險特約醫事服務機構藥事人員繼續教育認定要點」之意見進行調查，並探討我國藥師專業執業繼續教育現況。
本研究選擇中華民國藥師全國聯合會註冊之藥師，隨機抽樣篩選出3,706位受訪對象，並以受訪者自行填答方式之結構性問卷郵寄發送進行調查，其回收問巻為1,227份，回收率33.1%。研究結果顯示，受訪者對於「不同執業類型應給予不同的課程安排」、「繼續教育對工作上的專業形象有正向影響」及「繼續教育對於學校後教育的補強有意義」等項目同意度較高，其同意比率分別為86.2%、77%及75.9%。而受訪者中同意度較低的項目則為「繼續教育收取的費用合理性」、「為配合健保才修習繼續教育的合理性」及「現行繼續教育規範對於藥師專業技能及能力的提昇是足夠的」等三項，其同意比率分別為27.7%、37.7%及35.6%。
冀以本研究之探討，得以建議我國的專業執業繼續教育能隨各專業領域之不同需求，而量身訂製合適的教育課程內容，並使課程規劃得以統一及具多元化，建立繼續教育之整體規範及制度，而使藥事專業發展有一共同的目標與願景，並於醫藥分業與病人安全政策下，集合學會的力量匯集藥界菁英專才規劃擬定合適之藥事相關法規草案，促使衛生主管機關交付立法，以提昇藥師專業技能，建立社會大眾及醫療照護系統對藥師專業形象之認同，使台灣藥師專業執業繼續教育得以提昇。

關鍵字

藥師繼續教育認定要點 ； 繼續教育 ； 專業發展

並列摘要

3,706 participants of licensed pharmacists were enrolled by random sampling from the affiliate’s name list of the National Union of Pharmacist Associations of Republic of China(2004). A simple 2-page’s self-study instruments with 12 questions in 5-point scale was constructed. It was mailed to the participants in March 2005 and instruments werecoded for follow-up data collection. The pharmacist was asked to fill the questionnaire to elaborate current situation of continuing pharmacy education (CPE). The Reply rate was 33.1%. Results were based on 1,227 replied questionnaires. Statistical analysis was performed on SPSS software. The three questionnaire items of the most highest agreement were “should give the different curriculum for different professional practices”,“have positive effect on professional images”, “can build support for after-school professional education”, and their agreement rates were 86.2%, 77.0% and 75.9%, respectively. The three questionnaire items of the most lowest agreement were “the CPE program fee was reasonable”, “comply with the rules of bureau of national health insurance to learn”, “nowadays CPE standard can promote skills nad abilities of professional practice enough”, and their agreement rates were 27.7%, 37.7% and 35.6%, respectively.
The finding showed, the participant “should give the different curriculum arrangement regarding the different disciple of a master type”, “the continuing education has to in the work specialized image” and the continuing education educates to the influence “after the school makes up strongly has the significance” and so on profect agreement is higher. Its agreement ratio respectively is 86.2%, 77.0% and 75.9%. But in the participant agreed a lower profect is “the expense rationality which the continuing education gathers”, “only then repairs the custom continuing education for the coordinate health insurance the rationality” and “the present continuing education standard regarding the pharmcist specialized skill and the ability promotion is enough” and so on three items, Its agreement ratiorespectively is 27.7%, 37.7% and 35.6%.
The ultimate goal of CPE is to improve clinical practice and patient outcomes. Educational strategies may consider assessing the educational needs, background, and interests of potential participants. The teaching methods selected should be directed towards development of the desired knowledge and skills of participants. Individual motivation and administrative and institutional support are the essential components for success. There is no single, best model for the education and training of pharmacists, and principles and practices that should be employed by pharmacy education policy-makers to meet the needs of society locally, regionally and worldwide. The study proposing: 1. Assessing their learning and development needs; 2. Planning and implementing a structured learning program; 3. Recording and evaluating the resulting improvements in their professional practice.

並列關鍵字

continuing pharmacy education ； maintain professional competence

參考文獻

參考文獻

1.Mikeal RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am. J. Hosp. Pharm., 1975; 32 (6): 567-574.

2.American society of Hospital Pharmacists: ASHP statement on pharmaceutical care. Am. J. Hosp. Pharm., 1993; 50:1720-3.

3.Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc. 1997; 37:647-61.

4.Jungnickel PW, Wisehart DA, Evaluation of community pharmacists experiences with cholesterol screening programs. J Am Pharm Assoc. 1997; 37: 640-6.